ETBX-071

AXP000158.1 · Cancer vaccine

Platform
adenovirus (Ad5 [E1-, E2b-])
Targets
KLK3
Originator
Etubics
Sponsor
ImmunityBio

Names

NameTypeSource
ETBX-071preferred name, codecurator, ncit
Adenoviral PSA Prostate Cancer Vaccine ETBX-071 ambiguoussynonymncit
Adenoviral PSA Vaccine ETBX-071 ambiguoussynonymncit

Virus

Role
Vaccine vector
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 [E1-, E2b-]
Replication
non replicating
Modifications
E1 and E2b regions deleted (replication-defective, reduced late gene expression)
Transgenes
prostate-specific antigen (KLK3)
Route
subcutaneous
Source
evidence

Cross-references

NCI Thesaurus
C148142
FDA UNII
68TF9SDE9N

Approvals

No regulatory approval recorded.

Clinical trials (3)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06765902Immunotherapy Before and After SurgeryWithdrawnPhase 22025-12-152031-01-310High-risk Prostate Cancer
NCT06765954Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.WithdrawnPhase 22025-12-012031-01-310High-risk Prostate Cancer
NCT03481816Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy VaccinesCompletedPhase 12018-07-242020-01-1518Prostatic Cancer; Prostatic Neoplasms

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 33762322Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).Journal for immunotherapy of cancer2021cited by trial NCT03481816

Notes

Ad5 [E1-, E2b-] vector of the Etubics (now ImmunityBio) AdenoVerse-style platform, given subcutaneously; the E2b deletion is intended to allow repeat dosing despite pre-existing Ad5 immunity. Studied alone and in the multi-antigen Tri-Ad5 / 'Triad' regimens, which are combinations and not programs of their own. NCIt preferred name: Adenoviral PSA Vaccine ETBX-071.

How to cite

ETBX-071 (AXP000158.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000158.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.